XML 120 R107.htm IDEA: XBRL DOCUMENT v3.22.2.2
Line of Credit (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2022
Jan. 26, 2022
Jan. 25, 2022
Debt Instrument [Line Items]          
Period of notice required before prepaying the debt instrument     5 days    
Interest expense     $ 0.9    
Legal and other fees     0.1    
Aggregate borrowing capacity       $ 3.5 $ 1.0
Amortization of deferred financing costs     0.4    
Other Noncurrent Assets [Member]          
Debt Instrument [Line Items]          
Unamortized debt issuance expense     $ 0.1    
Revolving Credit Facility [Member]          
Debt Instrument [Line Items]          
Maximum borrowing capacity       $ 12.5 $ 25.0
Event Occurs on or before January 26, 2023 [Member]          
Debt Instrument [Line Items]          
Commitment fee percentage     2.00%    
Event Occurs After January 26, 2023 But On or Before January 26, 2024 [Member]          
Debt Instrument [Line Items]          
Commitment fee percentage     1.00%    
Event Occurs After January 26, 2024 But on or Before January 26, 2025 [Member]          
Debt Instrument [Line Items]          
Commitment fee percentage     0.50%    
Neos Therapeutics, Inc [Member] | Loan Agreement          
Debt Instrument [Line Items]          
Maximum borrowing capacity $ 25.0        
Maximum borrowing capacity portion available for short-term swingline loans $ 2.5        
Percentage of eligible accounts receivable against which short-term swingline loans may be made 85.00%        
Unused capacity commitment fee percentage 0.50%        
Interest expense   $ 0.2      
Outstanding amount   $ 7.9 $ 3.8    
Unused line of credit     $ 0.3    
Neos Therapeutics, Inc [Member] | Loan Agreement | London Interbank Offered Rate (LIBOR)          
Debt Instrument [Line Items]          
Basis spread on variable rate 4.50%